patientDerivedModelId,modelSystemType,patientDiagnosis,hostStrain,tumorType,engraftmentSite,passageNumber,establishmentRate,molecularCharacterization,clinicalData,humanizationMethod,immuneSystemComponents,validationMethods,_resourceName,_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType,_toolName
a238b29c-bfe1-5abe-9f2e-f019bf145305,PDX,NF1-associated tumor,NSG,,subcutaneous,,,,,,,,JH-2-002,PMID:41022755 | PMID:38000020 | PMID:33032988,10.1038/s41467-025-63619-4 | 10.1126/sciadv.adg8876 | 10.1158/0008-5472.CAN-20-1365,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"JH-2-002 and JH-2-031 patient-derived xenografts (PDX) were obtained from the Johns Hopkins NF1 biospecimen repository | eight PDXs [JH-2-002, JH-2-031, JH-2-079c, WU-225, WU-386, WU-545, MN-2, and MN-3-002] were generated in our laboratories | Four patient-derived MPNST cell lines (JH-2–002, JH-2–009, JH-2–031 and JH-2–055) | Minced tumor fragments from donor mice were implanted subcutaneously close to the sciatic nerves of 6 to 8-week-old athymic nude (NF90.8) or NSG (PDX JH-2–002) female mice",0.9,Accept,Experimental Usage,JH-2-002
df878292-d243-5bc5-8fe0-1c11a30decb5,PDX,NF1-associated tumor,NSG,,subcutaneous,,,,,,,,JH-2-031,PMID:41022755 | PMID:38000020 | PMID:33032988,10.1038/s41467-025-63619-4 | 10.1126/sciadv.adg8876 | 10.1158/0008-5472.CAN-20-1365,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"JH-2-002 and JH-2-031 patient-derived xenografts (PDX) were obtained from the Johns Hopkins NF1 biospecimen repository | eight PDXs [JH-2-002, JH-2-031, JH-2-079c, WU-225, WU-386, WU-545, MN-2, and MN-3-002] were generated in our laboratories | Four patient-derived MPNST cell lines (JH-2–002, JH-2–009, JH-2–031 and JH-2–055)",0.9,Accept,Experimental Usage,JH-2-031
0ad52ce6-3d08-5eae-afa7-4070c3f917b1,PDX,NF1-associated MPNST,,MPNST,,,,,,,,,JH-2-079c,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"eight PDXs [JH-2-002, JH-2-031, JH-2-079c, WU-225, WU-386, WU-545, MN-2, and MN-3-002] were generated in our laboratories",0.9,Accept,Experimental Usage,JH-2-079c PDX
8f471752-d637-59f2-9b80-30d1566f673a,PDX,NF1-associated MPNST,,MPNST,,,,,,,,,WU-225,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"eight PDXs [JH-2-002, JH-2-031, JH-2-079c, WU-225, WU-386, WU-545, MN-2, and MN-3-002] were generated in our laboratories",0.9,Accept,Experimental Usage,WU-225 PDX
18cdb28b-9cef-51f5-b411-2b0939e0724d,PDX,NF1-associated MPNST,,MPNST,,,,,,,,,WU-386,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"eight PDXs [JH-2-002, JH-2-031, JH-2-079c, WU-225, WU-386, WU-545, MN-2, and MN-3-002] were generated in our laboratories",0.9,Accept,Experimental Usage,WU-386 PDX
457d0b4b-25ae-5a5d-8dfc-f9cc116069aa,PDX,NF1-associated MPNST,,MPNST,,,,,,,,,WU-545,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"eight PDXs [JH-2-002, JH-2-031, JH-2-079c, WU-225, WU-386, WU-545, MN-2, and MN-3-002] were generated in our laboratories",0.9,Accept,Experimental Usage,WU-545 PDX
eb1ec3b8-3373-56da-811c-35ba7f43da05,PDX,NF1-associated MPNST,,MPNST,,,,,,,,,MN-2,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"eight PDXs [JH-2-002, JH-2-031, JH-2-079c, WU-225, WU-386, WU-545, MN-2, and MN-3-002] were generated in our laboratories",0.9,Accept,Experimental Usage,MN-2 PDX
64903d54-1f35-5c00-90d5-9dae1f854021,PDX,NF1-associated MPNST,,MPNST,,,,,,,,,MN-3-002,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"eight PDXs [JH-2-002, JH-2-031, JH-2-079c, WU-225, WU-386, WU-545, MN-2, and MN-3-002] were generated in our laboratories",0.9,Accept,Experimental Usage,MN-3-002 PDX
98820301-8821-5496-8914-0f29af4bac44,PDX,MPNST,NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ,MPNST,subcutaneous,,,,,,,,Patient-derived xenograft (PDX) MPNST model,PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,"For the patient-derived xenograft (PDX) MPNST model, tumor tissue was implanted subcutaneously directly into NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice",0.9,Accept,Experimental Usage,Patient-derived xenograft (PDX) MPNST model
878e2a16-a7c0-52f0-aae3-604a82662542,PDX,sporadic MPNST,athymic nude,MPNST,orthotopic,,,,,,,,MPNST-SP-01,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,significantly reduced tumor growth in a sporadic PDOX model (MPNST-SP-01; sevenfold),0.9,Accept,Experimental Usage,MPNST-SP-01 PDOX
1a1e5f49-9944-5fdc-a2bc-507f5a611d38,PDX,NF1-associated MPNST,athymic nude,MPNST,orthotopic,,,,,,,,MPNST-NF1-09,PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,and in an NF1-PDOX model (MPNST-NF1-09; fourfold),0.9,Accept,Experimental Usage,MPNST-NF1-09 PDOX
05082e19-1068-552d-b41a-8de52c52fc44,PDX,vestibular schwannoma,nude mouse,vestibular schwannoma,interscapular fat pad,,,,,,,,vestibular schwannoma xenografts,PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,Vestibular schwannoma xenografts were established in the interscapular fat pad in nude mice,0.9,Accept,Experimental Usage,vestibular schwannoma xenografts
22f0b8cc-5350-5fc3-82cc-8d0db0767a1b,organoid,NF1-associated cutaneous neurofibroma,,cutaneous neurofibroma,,,,,,,,,Cutaneous neurofibroma samples,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Cutaneous neurofibroma samples This work NF0001 – NF0012,0.9,Accept,Experimental Usage,Cutaneous neurofibroma samples
e3eae52e-f08c-50ac-a9cf-1cf261cce77e,PDX,plexiform neurofibroma,SCID,neurofibroma,subcutaneous,,,,,,,,human neurofibroma xenografts,PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,,Human neurofibromas were obtained from four patients with neurofibromatosis who underwent removal of plexiform neurofibroma,0.9,Accept,Experimental Usage,human neurofibroma xenografts
6a3d4fbb-c8ee-5d95-8b3d-f0b5b3991295,cell line,MPNST,,MPNST,,,,,,,,,RHT-92,PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"Following resection, patient tissue (18-year-old female) was initially expanded as flank tumours, harvested and expanded as a cell line, which were referred to as 'RHT-92'",0.9,Accept,Experimental Usage,RHT-92
14e76c31-31f8-5251-91e2-27ee74b3d931,PDX,NF1-associated MPNST,athymic nude,MPNST,subcutaneous (sciatic nerve),,,,,,,,NF90.8,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,Minced tumor fragments from donor mice were implanted subcutaneously close to the sciatic nerves of 6 to 8-week-old athymic nude (NF90.8) or NSG (PDX JH-2–002) female mice,0.9,Accept,Experimental Usage,NF90.8
